Results 21 to 30 of about 15,426 (247)

HIGH FREQUENCY OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN BRONCHIECTASIS-COPD OVERLAP.

Chest, 2021
BACKGROUND Allergic bronchopulmonary aspergillosis (ABPA) is associated with frequent exacerbations and poor outcomes in chronic respiratory disease but remains underdiagnosed.
P. Y. Tiew, Albert Yick Hou Lim, Holly R. Keir, A. Dicker, M. M. Aogáin, Sze Lei Pang, Low Teck Boon, T. Hassan, M. Poh, Huiying Xu, T. Ong, M. Koh, J. Abisheganaden, A. Tee, F. Chew, J. Chalmers, S. Chotirmall   +16 more
semanticscholar   +1 more source

All that glitters is not gold

Journal of Association of Pulmonologist of Tamil Nadu, 2021
In the midst of COVID pandemic, all cases presenting with lung infiltrates are assumed to be covid. However, other diagnoses are possible and a case of allergic bronchopulmonary aspergillosis which presented in the midst of the pandemic is highlighted ...
Vinod Kumar Viswanathan
doaj   +1 more source

Successful Treatment of Mepolizumab- and Prednisolone-resistant Allergic Bronchopulmonary Aspergillosis with Dupilumab

Internal medicine, 2021
A 45-year-old man with allergic bronchopulmonary aspergillosis (ABPA) was treated with oral prednisolone (PSL) (30 mg/day), inhaled corticosteroids, and long-acting beta2-agonists.
Sunao Mikura, T. Saraya, Yuki Yoshida, Miku Oda, M. Ishida, Kojiro Honda, K. Nakamoto, Masaki Tamura, S. Takata, H. Shimoyamada, M. Fujiwara, H. Ishii   +11 more
semanticscholar   +1 more source

Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial

European Respiratory Journal, 2021
Background In allergic bronchopulmonary aspergillosis (ABPA), prolonged nebulised antifungal treatment may be a strategy for maintaining remission. Methods We performed a randomised, single-blind, clinical trial in 30 centres.
C. Godet, F. Couturaud, S. Marchand-Adam, C. Pison, F. Gagnadoux, E. Blanchard, C. Taillé, B. Philippe, S. Hirschi, C. Andrejak, A. Bourdin, C. Chenivesse, S. Dominique, L. Bassinet, M. Murris-Espin, F. Rivière, G. Garcia, D. Caillaud, F. Blanc, F. Goupil, Anne Bergeron, A. Gondouin, J. Frat, T. Flament, B. Camara, P. Priou, A. Brun, F. Laurent, S. Ragot, J. Cadranel   +29 more
semanticscholar   +1 more source

New Clinical Diagnostic Criteria for Allergic Bronchopulmonary Aspergillosis/Mycosis and its Validation.

Journal of Allergy and Clinical Immunology, 2020
BACKGROUND There are several clinical diagnostic criteria for allergic bronchopulmonary aspergillosis (ABPA). However, these criteria have not been validated in detail, and no criteria for allergic bronchopulmonary mycosis (ABPM) is currently available.
K. Asano, A. Hebisawa, T. Ishiguro, N. Takayanagi, Yasuhiko Nakamura, J. Suzuki, N. Okada, Jun Tanaka, Y. Fukutomi, S. Ueki, K. Fukunaga, S. Konno, H. Matsuse, K. Kamei, M. Taniguchi, T. Shimoda, T. Oguma   +16 more
semanticscholar   +1 more source

Predicting Mortality in Intensive Care Unit Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) Using an Interpretable Machine Learning Model: A Retrospective Cohort Study. [PDF]

Can Respir J
Background Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity lung disease caused by Aspergillus infection, with severe cases often requiring admission to the intensive care unit (ICU). Early prediction of in‐hospital mortality in ICU ABPA patients is crucial for optimizing clinical decision‐making and resource allocation.
Zhang J, Tang J, Li J, Liu X, Sun Y, Wang P.   +5 more
europepmc   +2 more sources

Allergic bronchopulmonary aspergillosis: diagnostic and treatment challenges [PDF]

, 2016
Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder, occurring mostly in asthmatic and cystic fibrosis patients, caused by an abnormal T-helper 2 lymphocyte response of the host to Aspergillus fumigatus antigens.
CINICOLA, BIANCA LAURA, DUSE, MARZIA, Laitano, Rossella, LEONARDI, LUCIA   +3 more
core   +1 more source

Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis

Oxford Medical Case Reports, 2021
Allergic bronchopulmonary aspergillosis (ABPA) is a disease characterized by severe disability with recurrent wheezing and shortness of breath. The current recommended therapy is daily oral corticosteroids +/− oral antifungal therapy.
Muhammad Ali, O'Neil Green
semanticscholar   +1 more source

A unique case of hydropneumothorax in allergic bronchopulmonary aspergillosis

Medical Mycology Case Reports, 2019
Allergic bronchopulmonary aspergillosis (ABPA) is an immunologically mediated disease characterized by a hypersensitivity reaction to fungal colonization by Aspergillus.
Tejas Suri, Nayani Makkar, Animesh Ray, Rita Sood   +3 more
doaj   +1 more source

Prospective evaluation of a new Aspergillus IgG EIA kit for the diagnosis of chronic and allergic pulmonary aspergillosis [PDF]

, 2016
International ...
Bailly, S., Brenier-Pinchart, M. P., Camara, B., Cornet, M., Dumollard, C., Gangneux, Jean-Pierre, Grenouillet, F., Pelloux, H., Perriot, S., Persat, F., Pinel, C., Saint-Raymond, C., Valot, S.   +12 more
core   +4 more sources